Celebrex Case Solution Abstract: The case explains the advancement and United States release of Celebrex, the very first Cox-2 inhibitor, which is co-promoted by Pfizer and Searle. 4 months after launch Celebrex is dealing with 3 problems: (1) How to resolve the mix-ups in between Celebrex and 2 drugs with comparable names? Pedagogical Goals: […]